Goldman Sachs is likely to convert some of its loan to online pharmacy PharmEasy into equity. Buoyed by binding commitments from existing investors, the epharnacy also plans to pay back a considerable chunk of its debt following the rights issue in September. This and more in today’s ETtech Morning Dispatch.from Tech-Economic Times https://ift.tt/OVoFxwH
No comments:
Post a Comment